SEC Form 4 research
| Issuer | PHARMATHENE, INC |
|---|---|
| Tickers | HAQ, PIP, ALT |
| Reporting owners | 94 |
| Officers and directors | 28 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-02 | Greenleaf Peter | A | 160,000 | $0 | Not reported |
| 2026-11-04 | 2026-11-02 | Howarth Alex G. | A | 160,000 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | MENZIUSO RICHARD THOMAS | A | 36,234 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | MENZIUSO RICHARD THOMAS | A | 84,546 | $0 | Not reported |
| 2026-08-13 | 2026-08-13 | Durso Jerome Benedict | P | 15,000 | $2.95 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.